BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16584092)

  • 1. Prognostic significance of Ki67-negative blast cell clone in the high risk group of children treated for acute myeloid leukaemia.
    Nowicki M; Ostalska-Nowicka D; Miśkowiak B
    Folia Histochem Cytobiol; 2006; 44(1):49-52. PubMed ID: 16584092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between early treatment failure and Ki67 antigen expression in blast cells of children with acute lymphoblastic leukaemia before commencing treatment. A retrospective study.
    Nowicki M; Miśkowiak B; Kaczmarek-Kanold M
    Oncology; 2002; 62(1):55-9. PubMed ID: 11810044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia.
    Jain S; Mahapatra M; Pati HP
    Int J Lab Hematol; 2015 Dec; 37(6):746-51. PubMed ID: 26248894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic potential of bone marrow cyclin E and P27, in Egyptian patients with acute myeloid leukemia.
    Abdel Alim A; Youssef SR; Farouk HM
    Egypt J Immunol; 2010; 17(1):9-18. PubMed ID: 22053605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new prognostic stratification for patients with acute myeloid leukemia].
    Jiang B; Mi YC; Lin D; Cai XJ; Fu MW; Li W; Wang Y; Liu XP; Xue YP; Bian SG; Wang JX
    Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):316-20. PubMed ID: 19576124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy.
    Ballo O; Stratmann J; Serve H; Steffen B; Finkelmeier F; Brandts C
    PLoS One; 2019; 14(9):e0223013. PubMed ID: 31568521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
    Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
    Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
    Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ
    Cancer; 2012 Nov; 118(21):5278-82. PubMed ID: 22517268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
    Campuzano-Zuluaga G; Deutsch Y; Salzberg M; Gomez A; Vargas F; Elias R; Kwon D; Goodman M; Ikpatt OF; Chapman JR; Watts J; Vega F; Swords R
    Am J Hematol; 2016 Mar; 91(3):277-82. PubMed ID: 26663264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome.
    Herst PM; Howman RA; Neeson PJ; Berridge MV; Ritchie DS
    J Leukoc Biol; 2011 Jan; 89(1):51-5. PubMed ID: 20959411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis.
    Galli S; Zlobec I; Schürch C; Perren A; Ochsenbein AF; Banz Y
    Leuk Res; 2015 Jul; 39(7):749-56. PubMed ID: 25943033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
    Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
    Wongprajun S; Auewarakul CU
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cytogenetic abnormalities in acute myeloid leukaemia.
    Harani MS; Adil SN; Kakepoto GN; Khilji Z; Shaikh U; Khurshid M
    J Pak Med Assoc; 2006 Jan; 56(1):9-13. PubMed ID: 16454127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group.
    Kinoshita A; Miyachi H; Matsushita H; Yabe M; Taki T; Watanabe T; Saito AM; Tomizawa D; Taga T; Takahashi H; Matsuo H; Kodama K; Ohki K; Hayashi Y; Tawa A; Horibe K; Adachi S
    Br J Haematol; 2014 Oct; 167(1):80-6. PubMed ID: 25039450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia: 2013 update on risk-stratification and management.
    Estey EH
    Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival.
    Tzankov A; Strasser U; Dirnhofer S; Menter T; Arber C; Jotterand M; Rovo A; Tichelli A; Stauder R; Günthert U
    Ann Hematol; 2011 Aug; 90(8):901-9. PubMed ID: 21274712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.